PriceSensitive

Else Nutrition (TSX:BABY) releases Q1 financial results

Consumer, Sponsored, The Watchlist
18 May 2022 10:15 (EDT)

This browser does not support the video element.

Else Nutrition (BABY) reported first-quarter 2022 financial results for the period ending March 31, 2022.

Q1 2022 financial highlights

Business highlights

Q2 2022 outlook

Hamutal Yitzhak, CEO of Else Nutrition sat down with Coreena Robertson to highlight the company’s results, discuss plans for the upcoming quarter and outline how Else is helping address the shortage of infant formula in the U.S.

“We are experiencing a wave of growth driven by the formula shortage crisis. Many consumers and retailers recognize our ability to bring unique solutions to families in this troublesome situation.

We see a strong acceleration in sales on Amazon.com, and other channels, driven by new and existing customers. While revenues on Amazon.com already increased by 40 per cent QoQ in 1Q22, our Amazon.com daily sales doubled in the last few days. In addition, the number of Else subscribers on Amazon.com grew by 20 per cent over the previous four weeks, reaching more than 1200. The retail demand is also increasing, and we expect entry to major nation wide brick and mortar retail channels in the coming months.“

Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults.

Else Nutrition Holdings Inc. (BABY) opened trading at C$1.25 per share.

Related News